Bioventus to Release Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021
27. Oktober 2021 16:15 ET
|
Bioventus, Inc.
DURHAM, N.C., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that third quarter of...
Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus
26. Oktober 2021 16:15 ET
|
Bioventus, Inc.
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, and Misonix,...
BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration
18. Oktober 2021 08:00 ET
|
Bioventus, Inc.
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), today announced an election deadline of 5:00 p.m.,...
DUROLANE® Among High-Molecular Weight Hyaluronic Acid Treatments Linked to Significant Improvements in Knee Osteoarthritis Pain by American Academy of Orthopaedic Surgeons
20. September 2021 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc., (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in innovations for active healing, announced that the American Academy of...
Bioventus Proceeds with Option Structure Agreement with CartiHeal
30. August 2021 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has elected to make a $50 million...
Bioventus Invests in Trice Medical Minimally Invasive Technologies
25. August 2021 16:05 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed a strategic investment...
Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer
23. August 2021 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has appointed Dave Crawford as its...
Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance
10. August 2021 16:05 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix
29. Juli 2021 16:05 ET
|
Bioventus, Inc.
Significantly Expands TAM and Adds Considerable Scale and Scope in Spine and Lower ExtremityEnhances Surgical Solutions Vertical by Adding Minimally Invasive Ultrasonic Technologies That Improve...
Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance
29. Juli 2021 16:00 ET
|
Bioventus, Inc.
DURHAM, N.C., July 29, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported preliminary financial...